I. Dotan

B cell receptor–based hybridoma enrichment enables discovery of antibodies against intracellular tumor antigens

Tumor-associated B cell responses are frequently observed in tumors and their draining lymph nodes, yet their antigen specificities and functional potential remain incompletely defined. Historically, intracellular antigens have been largely disregarded in tumor antigen mining and discovery efforts. In particular, the e...